About Us
Awards
News & Events
Product Login
JA
EN - United States
JP - Japanese
Contact Us
Menu
商業化
Commercial
Citeline商業 — ジャーナリストとアナリストの相互接続ネットワークによって支えられており、製薬業界の総合ニュースと、グローバルなライフサイエンスおよびバイオテクノロジー市場に対する戦略的洞察を提供します。
View all commercialization solutions
すべての商業製品を表示
バイオテクノロジーのキックスターター
競合他社分析
データ分析とコンサルティングサービス
HCPマーケティングソリューション
ライフサイエンスマーケティングソリューション
市場評価
ニュースと洞察
パートナーの優先順位付け
Pharmacy Market Access Solutions
UK Pharmacy Marketing Solutions
UK Pharmacy and healthcare solutions
臨床
臨床
Citeline臨床は、ライフサイエンス業界に総合的なリアルタイムの研究開発情報を提供し、世界の臨床試験、認定治験責任医師、治験実施施設、医薬品開発パイプラインの比類のないデータ収集を特徴としています。弊社のコンテンツは、業界最大の専門家アナリストチームによって編集されるので、Citeline臨床は市場で最も信頼される研究開発情報源です。
すべての臨床ソリューションを表示
臨床製品を表示
計画とプロトコルの最適化
臨床試験CROソリューション
研究管理と報告
データ分析とコンサルティングサービス
実現可能性と治験実施施設選択
HCPマーケティングソリューション
ライフサイエンスマーケティングソリューション
ニュースと洞察
患者エンゲージメントとリクルート
リアルワールドデータソリューション
規制とコンプライアンス
Regulatory & Compliance
Citeline規制とコンプライアンスは、臨床試験情報開示コンプライアンスを維持し、リスクを軽減し、透明性を高め、ブランドの評判を保護するために必要な情報、ツール、サービスをスポンサーに提供します。
View Regulatory & Compliance products
データ分析とコンサルティングサービス
ライフサイエンスマーケティングソリューション
ニュースと洞察
規制計画と戦略
研究管理と報告
Resources
Resources
View all resources
Article
Bayer Precision Health
The Ins and Outs of Decentralized Clinical Trial Technologies
Clinical Trial Diversity on a Global Scale
Clinical Trial Recruitment: Meeting Patients Where They Are
3 Ways Clinical Trial Diversity Can Put Sponsors On Top
Bayer OTC Digital Therapeutics AI
Balancing Medtech Innovation with Safety
EU AI Act Legal Deep-Dive Part 1: What Can Medtech Expect, and When?
Floodgates Open for US Humira Biosimilars; Key TB Drug Can Move in India
Generics Bulletin Explains: The Next Wave of US Humira Biosimilars
How Advocacy Groups Can Motivate Patients to Participate in Clinical Trials
Medtech Innovation with Safety
Patient Voice to Data: How Novartis Is Listening Up, Harnessing RWE in APMA
Technology & the Triple Aim of Trial Recruiting
The need for clinical trial diversity
Case Study
Astrazeneca Trial Results Summaries
Citeline Connect key to record-setting clinical trial recruitment
Rezolute Pediatric Trial Case Study
Small Biotech Maintains Disclosure Compliance
eBook
Understanding EU Transparency
Infographic
9 Hidden Costs of Trial Disclosure
In Vivo Rising Leaders 2023
Supporting diversity in clinical trial recruitment
Podcast
A Man on Fire Fueled by a Mission to Find a Drug for Every Disease
Medtech Connect Podcast DCT
Quick Listen: Scrip's Five Must-Know Things
The EU Green Claims Directive
Press Release
Citeline And EMIS Partner To Expand Clinical Trial Access In The UK
Citeline Appoints Clinrol as Strategic Clinical Trial Partner Across APAC Region
Citeline Connect and ProofPilot Announce Strategic Partnership
Citeline Launches TrialScope Intelligence
Citeline to Unveil Capabilities of New Clinical Trial Workflow Solution at SCOPE 2023 in Orlando
Finalists 2023 - Citeline Pharma Intelligence Awards Japan
Hemophilia Federation of America Launches Clinical Trial Finder Powered by Citeline Connect
Introducing Citeline Sitetrove Diversity Module
Introducing Pharma Ignite: the Catalyst for Innovative Pharma Marketing Solutions
Primal Pictures And The Anatomical Society Partner
UK Community Pharmacists Survey 2022 80 Consider Leaving
Report
2023 Pre-ASCO Report
In Vivo Outlook 2023
Q2 2023 Pharma Outlook Report
Q3 2023 Pharma Outlook Report
Use Case
Accelerating Diversity Enrollment In A Phase- III Covid-19 Clinical Trial
Real World Data Resource Bundle
Webinars
On-demand Clinical Connection Digital Week
新薬開発とアライアンス:現状と展望
White Paper
2022 Clinical Trials Roundup
2022 Deal-Making Roundup
Clinical Documents for CTIS Submission: Navigating the Privacy Tightrope
Citeline Pharma R&D Annual Review 2023
Clinical Trial Disclosure Compliance A Moving Target
2022 Completed Trials: A Roller Coaster Ride for Sponsors
Global Clinical Trial Disclosure: What Noncompliance Penalties Are in Place, & How They Are Enforced
Pharma R&D Annual Review 2023 NAS Supplement
The Need for Better Clinical Trial Diversity Data
The State of Innovation in Europe
Trial Summaries Patient Centricity
Unlocking DCT Potential
Bayer Precision Health
The Ins and Outs of Decentralized Clinical Trial Technologies
Clinical Trial Diversity on a Global Scale
Clinical Trial Recruitment: Meeting Patients Where They Are
3 Ways Clinical Trial Diversity Can Put Sponsors On Top
Bayer OTC Digital Therapeutics AI
Balancing Medtech Innovation with Safety
EU AI Act Legal Deep-Dive Part 1: What Can Medtech Expect, and When?
Floodgates Open for US Humira Biosimilars; Key TB Drug Can Move in India
Generics Bulletin Explains: The Next Wave of US Humira Biosimilars
How Advocacy Groups Can Motivate Patients to Participate in Clinical Trials
Medtech Innovation with Safety
Patient Voice to Data: How Novartis Is Listening Up, Harnessing RWE in APMA
Technology & the Triple Aim of Trial Recruiting
The need for clinical trial diversity
Astrazeneca Trial Results Summaries
Citeline Connect key to record-setting clinical trial recruitment
Rezolute Pediatric Trial Case Study
Small Biotech Maintains Disclosure Compliance
Understanding EU Transparency
9 Hidden Costs of Trial Disclosure
In Vivo Rising Leaders 2023
Supporting diversity in clinical trial recruitment
A Man on Fire Fueled by a Mission to Find a Drug for Every Disease
Medtech Connect Podcast DCT
Quick Listen: Scrip's Five Must-Know Things
The EU Green Claims Directive
Citeline And EMIS Partner To Expand Clinical Trial Access In The UK
Citeline Appoints Clinrol as Strategic Clinical Trial Partner Across APAC Region
Citeline Connect and ProofPilot Announce Strategic Partnership
Citeline Launches TrialScope Intelligence
Citeline to Unveil Capabilities of New Clinical Trial Workflow Solution at SCOPE 2023 in Orlando
Finalists 2023 - Citeline Pharma Intelligence Awards Japan
Hemophilia Federation of America Launches Clinical Trial Finder Powered by Citeline Connect
Introducing Citeline Sitetrove Diversity Module
Introducing Pharma Ignite: the Catalyst for Innovative Pharma Marketing Solutions
Primal Pictures And The Anatomical Society Partner
UK Community Pharmacists Survey 2022 80 Consider Leaving
2023 Pre-ASCO Report
In Vivo Outlook 2023
Q2 2023 Pharma Outlook Report
Q3 2023 Pharma Outlook Report
Accelerating Diversity Enrollment In A Phase- III Covid-19 Clinical Trial
Real World Data Resource Bundle
On-demand Clinical Connection Digital Week
新薬開発とアライアンス:現状と展望
2022 Clinical Trials Roundup
2022 Deal-Making Roundup
Clinical Documents for CTIS Submission: Navigating the Privacy Tightrope
Citeline Pharma R&D Annual Review 2023
Clinical Trial Disclosure Compliance A Moving Target
2022 Completed Trials: A Roller Coaster Ride for Sponsors
Global Clinical Trial Disclosure: What Noncompliance Penalties Are in Place, & How They Are Enforced
Pharma R&D Annual Review 2023 NAS Supplement
The Need for Better Clinical Trial Diversity Data
The State of Innovation in Europe
Trial Summaries Patient Centricity
Unlocking DCT Potential
製品とサービス
製品とサービス
View all products & services
Commercial
すべての商業製品を表示
Biomedtracker
C + D Data
C + D News
Datamonitor Healthcare
Generics Bulletin
HBW Insight
In Vivo
Meddevicetracker
Medtech Insight
Primal Pictures
Scrip
Skipta
臨床
View All Clinical Products
Feasibility as a Service
Pharmaprojects
Sitetrove
Sitetrove: Diversity Module
Trialtrove
患者エンゲージメントとリクルート
View All Patient Engagement & Recruitment Products
Citeline Connect
Community Portal
HCP Awareness
Patient Recruitment Collective
Clinical Trial Portfolio Website
Trial Results Summaries
Regulatory & Compliance
View All Regulatory & Compliance Products
Pink Sheet
Trialscope Disclose
Trialscope Intelligence
カスタムソリューション
View All Custom Solutions
分析ソリューション
Informatics Solutions
コンサルティング
Preferred Partner Network
Third Party Access
リアルワールドデータソリューション
Marketing
View All Marketing Solutions
C+D Advertising & Marketing Services
Pharma Ignite
Skipta
すべての商業製品を表示
Biomedtracker
C + D Data
C + D News
Datamonitor Healthcare
Generics Bulletin
HBW Insight
In Vivo
Meddevicetracker
Medtech Insight
Primal Pictures
Scrip
Skipta
View All Clinical Products
Feasibility as a Service
Pharmaprojects
Sitetrove
Sitetrove: Diversity Module
Trialtrove
View All Patient Engagement & Recruitment Products
Citeline Connect
Community Portal
HCP Awareness
Patient Recruitment Collective
Clinical Trial Portfolio Website
Trial Results Summaries
View All Regulatory & Compliance Products
Pink Sheet
Trialscope Disclose
Trialscope Intelligence
View All Custom Solutions
分析ソリューション
Informatics Solutions
コンサルティング
Preferred Partner Network
Third Party Access
リアルワールドデータソリューション
View All Marketing Solutions
C+D Advertising & Marketing Services
Pharma Ignite
Skipta
About Us
Awards
News & Events
Product Login
Contact Us
JA
EN - United States
JP - Japanese
Home
/
Resources
/
ASGCT Q3 2023 Report
Gene, Cell, + RNA Therapy Landscape Q3 2023 Report
Report
Commercial
OCT 01, 2023
Q3 2023 saw 3,866 therapies in development; 53% of those were gene therapies, 25% RNA therapies, and 22% non-genetically modified cell therapies.
Register for free content
Clinical Trial Disclosure
名
*
姓
*
勤務先
*
役職名
*
勤務先メールアドレス
*
国
*
Please select
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
Brit/Indian Ocean Terr.
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Dem. Republic Of
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Terr.
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Heard/McDonald Isls.
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea (North)
Korea (South)
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
N. Mariana Isls.
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Samoa
San Marino
Sao Tome/Principe
Saudi Arabia
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
St. Vincent and Grenadines
Sudan
Suriname
Svalbard/Jan Mayen Isls.
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks/Caicos Isls.
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
US Minor Outlying Is.
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Viet Nam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis/Futuna Isls.
Western Sahara
Yemen
Zambia
Zimbabwe
勤務先電話番号
*
産業セグメント
*
担当領域
*
職務
*
Citeline may contact you about relevant products, services and content. To opt-out of these communications or to manage what you receive, please visit our
Preference Center
.
Your information will be used in accordance with our
Privacy notice
.
このボックスをチェックすることで、インフォーマビジネスインテリジェンスからの関連ニュース、最新情報、オファー、および製品ポートフォリオから厳選された類似製品などのEメールを受信することに同意します。
Please confirm you are not a robot.
elqSiteID